IVIM Health GLP-1 Reviews (2026): Real Cost, FDA Warning Letter, and Who It's Actually Right For
By Weight Loss Provider Guide Research Team · Last verified: · Next check:
The Short Answer, Up Front
Here's the IVIM Health GLP-1 reviews verdict in one breath: IVIM is a real, operating telehealth company with licensed providers, 36,622 Trustpilot reviews, BBB A+ accreditation since February 2023, and peer-reviewed published clinical outcomes. Once you count the $75/month membership (first month free), the real effective monthly cost is $143.75/month for compounded semaglutide on a 12-month plan, not the "starting at $75" number the home page leads with.
Active FDA Warning Letter — February 20, 2026
The FDA issued IVIM a warning letter about product labeling — specifically that website images implied IVIM was the compounder of its semaglutide and tirzepatide when it isn't. This is about labeling, not medication safety or a recall. Read the full letter →
| Legit? | Yes — founded 2021, BBB A+, 36,622 Trustpilot reviews, peer-reviewed published outcomes |
| Best for | Cost-conscious buyers committing to 6–12 months who want hands-on support |
| Not for | Month-to-month shoppers, insurance-covered medication seekers, brand-name-only buyers |
| Real all-in monthly | $143.75 (12-mo sema) · $162.50 (6-mo sema) · $202.08 (12-mo tirz) · $245.83 (6-mo tirz) |
| Biggest caution | Multi-month plans have no mid-term cancellation — you're committed through the term |
| States | Mississippi excluded (per IVIM's own disclosures) |
Free consultation. No payment required to meet with a provider.
What We Actually Verified
Every commercial fact below was pulled from a primary source on April 23, 2026:
- IVIM's official pricing page, home page, semaglutide page, and tirzepatide page
- IVIM's Subscription Agreement, Terms and Conditions, and Returns Policy
- FDA Warning Letter to Ivim Services LLC, February 20, 2026
- IVIM's peer-reviewed clinical study in Obesity Pillars
- Live Trustpilot, BBB, Apple App Store, and Google Play ratings and complaint records
- FDA guidance on compounded GLP-1 medications
We re-verify monthly for pricing and FDA status, quarterly for everything else. Next scheduled verification: May 23, 2026.
Is IVIM Health Legit, or Is It a Scam?
IVIM Health is a real telehealth company, not a fake storefront. It was founded in 2021 in Columbus, Ohio by Dr. Taylor Kantor, his brother Anthony, and Anthony's wife Kelly. It employs 92+ licensed medical providers — including board-certified obesity medicine physicians and nurse practitioners. It has been BBB-accredited with an A+ rating since February 2023, has published clinical outcomes in a peer-reviewed journal (Obesity Pillars), and has active iOS and Android apps with thousands of real ratings.
"Legit" isn't the same as "friction-free." IVIM also has a live FDA warning letter and a meaningful BBB complaint volume. Here's how each piece fits.
What proves IVIM is a real operating company
Licensed clinicians with real names
Multiple Trustpilot reviewers name specific providers — Dr. Jessica Duncan (IVIM's Medical Director, a Diplomate of the American Board of Obesity Medicine), NP Amanda Mertens, NP Connie, NP Courtney Goode, and others — in first-person reviews.
Peer-reviewed published outcomes
A retrospective study of 1,131 IVIM patients on semaglutide in Obesity Pillars. Most competitors have no published data at all.
Registered entity with a real address
Ivim Services LLC, 4200 Regent Street, Suite 200, Columbus, OH 43219. The FDA used that exact address on the warning letter, confirming the corporate identity from an independent government source.
Active mobile apps with live ratings
iOS: approximately 4.7 stars across 7,400+ ratings. Android: approximately 4.2 stars across 1,340+ reviews.
The FDA Warning Letter: What It Actually Says
On February 20, 2026, the FDA's Center for Drug Evaluation and Research issued a warning letter to Ivim Services LLC. The agency had reviewed IVIM's website in December 2025 and found that images of compounded semaglutide and tirzepatide products displayed labels bearing the name "Ivim." Under FDA rules, putting a name on a drug label can constitute branding that drug as the labeled entity's product — but IVIM doesn't compound the medication itself. The actual compounder is a separate licensed pharmacy. The warning says IVIM's labeling representation was misleading about who manufactured the product.
What the warning does NOT say
- The FDA did not say IVIM's medications are unsafe
- The FDA did not say the medications are contaminated or incorrectly dosed
- It is not a recall
- It is not a shutdown of IVIM's operations
- It is not a finding about the compounding pharmacies IVIM partners with
What it does mean in practice
- IVIM needs to update its product imagery so the actual compounder is identified
- Readers who want zero regulatory friction have a legitimate reason to pause
- The issue is about marketing representation, not the medication itself
- The FDA gave IVIM 15 working days to respond
What Changed After the FDA Warning Letter
| Question | As of April 23, 2026 |
|---|---|
| Has IVIM publicly responded? | No public announcement from IVIM specifically addressing warning letter #721816 has been issued at the time of our verification. |
| Has the FDA updated the warning letter's status? | No close-out letter or follow-up action has been posted by the FDA as of our verification date. |
| Has IVIM changed its product imagery on its website? | IVIM's current medication pages continue to use 'Ivim' branding on product imagery as of our verification. We will update this page when that changes. |
| Is IVIM still operating and accepting new patients? | Yes — the company remains fully operational. |
We check this table monthly. If you're reading this later and the status hasn't been updated, email us and we'll re-verify.
Where IVIM Sits on Every Public Trust Signal
| Trust signal | Verified value (April 23, 2026) | Our read |
|---|---|---|
| Trustpilot | 4.9 stars, 36,622 reviews | One of the largest review footprints in GLP-1 telehealth |
| BBB | A+ accredited since Feb 2023; complaint categories below | Accredited and responsive; real complaint history |
| Apple App Store | ~4.7 stars, 7,400+ ratings | The app is a genuine asset |
| Google Play | ~4.2 stars, 1,340+ reviews | Lower than iOS; Android friction is real |
| Peer-reviewed publication | Obesity Pillars study, 1,131 patients | Very few GLP-1 telehealth companies have this |
| Provider team | 92+ licensed providers | Company-reported; consistent with independent reviews naming providers |
| FDA warning letter | Feb 20, 2026 — misbranding (labeling) | Active, open matter; labeling, not safety |
If you want compounded GLP-1 access from a provider without an open FDA matter, Ro focuses on FDA-approved brand-name options.
How Much Does IVIM Health Really Cost?
IVIM's advertised "starting at" prices leave the $75/month membership fee out of the math. Accounting for membership (first month free), the true effective monthly cost is $143.75/month for compounded semaglutide on the 12-month plan and $202.08/month for compounded tirzepatide on the 12-month plan.
Where IVIM's own "starting at" numbers disagree with each other
| Page | Number IVIM shows | What's missing |
|---|---|---|
| Home page | "Semaglutide starts at $75/mo, tirzepatide at $149/mo" + a $74.99/mo program fee | Plan length; full math |
| Semaglutide page | "Starting at $149/mo" | Plan length; term totals |
| Tirzepatide page | "Starting at $224/mo" | Plan length; term totals |
| Pricing page | 6- and 12-month totals due today, with first month of membership free, then $75/mo | This page gives the full picture |
The full IVIM cost decoder (verified April 23, 2026)
| Program | Due today | Membership (mo 2–end) | Total cost | Effective monthly |
|---|---|---|---|---|
| Compounded semaglutide, 12-month plan | $900 | $75 × 11 = $825 | $1,725 | $143.75/mo |
| Compounded semaglutide, 6-month plan | $600 | $75 × 5 = $375 | $975 | $162.50/mo |
| Compounded tirzepatide, 12-month plan | $1,600 | $75 × 11 = $825 | $2,425 | $202.08/mo |
| Compounded tirzepatide, 6-month plan | $1,100 | $75 × 5 = $375 | $1,475 | $245.83/mo |
| Compounded liraglutide | Starting $249/mo | $75/mo after mo 1 | Varies | ~$322/mo effective |
| Wegovy Pill (self-pay) | Per IVIM pricing page | $75/mo membership applies | Verify at checkout | Varies |
Optional add-ons (billed separately)
- Lipotropic (fat-burner) injections: $99/mo (1-mo) or $150 (2-mo)
- Sermorelin sublingual tablets: $129/mo (1-mo) or $297 (2-mo)
- NAD+ weekly injections: $249/mo (1-mo) or $375 (2-mo)
Does IVIM Health take insurance?
IVIM says it can help navigate insurance coverage and prior-authorization submissions for eligible brand-name GLP-1 prescriptions (Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda). Per IVIM's own prior-auth page, plans that do not cover weight-loss medications — including Medicare, Medicaid, Tricare, and Kaiser Permanente — may be automatically denied without a submission. The $75/month membership is cash-pay only. Compounded medications are cash-pay only — that's standard across the industry.
The sales pages say HSA/FSA cards are accepted at checkout. IVIM's Subscription Agreement specifies that subscription fees are not eligible for insurance reimbursement without independent verification. Translation: the medication charge is generally straightforward for HSA/FSA; the membership fee may or may not be reimbursable depending on your plan administrator. Verify with your administrator before enrolling — not after. Klarna financing is also available, which lets you split the upfront medication payment into installments.
Free consultation — no payment required to meet with a provider.
What Do You Actually Get for the $75/Month Membership?
The $75/month membership is the thing that makes IVIM either clearly worth it or clearly not — depending on what you value. The fee covers unlimited provider visits, weekly dose adjustments through IVIM's GLP-1 ID protocol, 1-on-1 health coaching, nutrition support, a mobile app with progress tracking and a meal builder, private member community access, 24/7 clinical support, and 20% off all supplements. The medication is billed on top of that.
If you want a structured program, it's strong. If you just want a prescription shipped to your door, you're paying for features you won't use.
Unlimited provider access
This is what comes up most in IVIM's positive reviews. Members can book or message a provider any time at no additional cost. That matters especially for patients sensitive to side effects, first-timers nervous about the early weeks, and patients managing comorbid conditions (PCOS, insulin resistance, prediabetes).
GLP-1 ID — weekly dose adjustments
Instead of a fixed titration schedule (one dose for 4 weeks, then up), IVIM providers adjust your dose based on how you're responding each week. The goal is to find the dose that gives you the most benefit with the least side effect burden, rather than following a standardized ramp.
Mobile app (iOS + Android)
The IVIM app tracks daily shots, weight, side effects, meals, and progress. Positive reviews specifically call out the app's meal builder and weekly check-in structure. Android users report more friction than iOS users — this is the most consistent platform-specific complaint.
Health coaching + community
Members get access to 1-on-1 health coaching and a private member community. For some patients, the accountability structure is the primary reason GLP-1 therapy works long-term — the medication creates the window; the coaching helps you use it.
No payment required to meet with a provider.
Does IVIM Health Actually Work? What the Published Study Shows
IVIM Health is one of very few GLP-1 telehealth providers with peer-reviewed published clinical outcomes. Their retrospective study in Obesity Pillars tracked 1,131 patients on semaglutide within IVIM's program. Headline results: average 19.5% total body weight loss at 52 weeks, 21.8% at 68 weeks. These are strong numbers — but it's an observational study, company-authored, and not a head-to-head trial against other providers.
| Dimension | What the study reports |
|---|---|
| Design | Retrospective observational analysis |
| Cohort size | 1,131 patients |
| Medication | Semaglutide — both FDA-approved branded (~4.6% of cohort) and compounded (~95.4% of cohort) |
| Timeframe | Up to 68 weeks of follow-up |
| Weight loss at 52 weeks | 19.5% average total body weight loss |
| Weight loss at 68 weeks | 21.8% average total body weight loss |
| What it proves | IVIM-cohort patients who stayed on therapy lost meaningful weight, consistent with semaglutide's established efficacy |
| What it does not prove | That compounded semaglutide is equivalent to FDA-approved semaglutide, or that IVIM's outcomes would replicate in a different population |
The intellectually fair read:
IVIM reported average app usage on 52 unique days per year per patient and 12.7 care-team touchpoints per year per patient. What the study genuinely tells you is less about the medication — semaglutide's effects are well-established — and more about what a structured support program does for adherence. GLP-1s only work if you stay on them, and staying depends on how well the program helps you through the first 8–12 weeks. IVIM's evidence is consistent with "our program helps more patients stay adherent long enough to see results."
We won't tell you compounded semaglutide is "clinically proven" to produce specific results or that it's identical to Wegovy — those claims aren't permitted for compounded medications under FDA rules. What we will say is that IVIM has more published evidence on its program than virtually any competitor in this space.
No payment required to meet with a provider.
How Cancellation Actually Works — The One Part of IVIM That Deserves the Whole Truth
This is the most important section on this page, and it's where most IVIM reviews go soft. IVIM's Subscription Agreement states that all program fees are non-refundable once payment terms are accepted, and that you are contractually obligated through the full duration of the program you select — regardless of usage or early cancellation.
The exact language from IVIM's own terms
- "All fees are non-refundable once payment terms are accepted."
- "You are contractually obligated to pay all remaining amounts due through the full duration of the program selected, regardless of usage or early cancellation."
- "By completing your purchase, you agree to all recurring charges and affirm that you understand the commitment and cancellation limitations of the selected program."
Early-out restocking fees
| Scenario | Fee | Waived if... |
|---|---|---|
| Cancel early on a plan with 3-month portions remaining | $100 per undeveloped 3-month portion | Provider determines you're medically ineligible to continue |
| Cancel early on a 4- or 6-month plan with 2-month portions remaining | $50 per undeveloped 2-month portion | Provider determines you're medically ineligible to continue |
| Cancel month-to-month $75 membership | No fee — 48 hours' notice required before renewal | N/A — standard cancellation |
The pivot — and why it still makes IVIM the right pick for most prepaid buyers
IVIM does NOT give you month-to-month flexibility on multi-month plans. If walking away after 30 days is important to you, IVIM is the wrong fit and a no-commitment provider like Eden (monthly) or Hims is better. But because IVIM requires plan-length prepayment, they can offer a lower effective monthly rate — roughly $30–$50/month less than flexible competitors. Over 12 months, that gap is $360–$600. That prepayment commitment is what funds the value stack — unlimited provider visits, coaching, app, community.
How Does Shipping and Pharmacy Fulfillment Work?
IVIM Health is not itself a pharmacy. Prescriptions are filled by licensed pharmacies not owned or operated by IVIM. After provider approval and payment processing, compounded medications ship directly from a partnered compounding pharmacy; brand-name medications go to your local pharmacy for pickup. Official shipping timeline: 7–14 days for compounded orders.
The refill flow in plain English
- Provider approves the refill — at a scheduled check-in or through in-app messaging. On multi-month plans, refills are handled as part of the program.
- Payment is processed — automatic for multi-month prepaid plans; billed on your membership cycle for single-month plans.
- Pharmacy prepares and ships — 7–14 days. Compounded products require the pharmacy to prepare the specific formulation, which adds time vs. a pre-made brand-name pen.
- You receive the medication — compounded ships directly; brand-name goes to your local pharmacy for pickup.
IVIM partners with outside licensed compounding pharmacies, not a single in-house facility. IVIM states its pharmacy partners follow USP standards. IVIM does not consistently disclose the specific compounding pharmacies by name in its public marketing — which was part of what triggered the FDA's labeling concern. If you want a provider that names its compounding pharmacy partners directly in marketing materials, that's an area where some competitors are more transparent than IVIM.
Request refills at least 10 days before you run out; keep 1–2 extra days of doses on hand; confirm the multi-month shipment schedule at enrollment; use the IVIM app's medication tracker as your reminder.
What Do Real IVIM Health Customers Say?
IVIM's review footprint is one of the largest in GLP-1 telehealth: 36,622 Trustpilot reviews at a 4.9-star average as of our verification. The dominant positive pattern: patients praise individual providers by name, the weekly dose-adjustment approach, fast appointment availability, and the feeling of ongoing partnership. The dominant negative pattern: operational issues (billing, shipping delays, app friction on Android) — not clinical conduct.
"Monica described joining IVIM specifically because of unlimited one-on-one consults with licensed practitioners, calling out NP Molly for walking her through dosage and side-effect questions — the kind of hand-holding that fixed-protocol platforms don't include."— Trustpilot review, ivimhealth.com
"A long-time dieter noted IVIM was the only provider she found with an app purpose-built around the program, integrating simple daily tracking with educational content and personalized macro recommendations."— Apple App Store review
"Very disappointed considering what I'm paying" — after losing tracked data in the app. A value-for-money complaint, not a medical one.— Apple App Store review
Reviews reflect individual customer opinion, not verified medical outcomes. Individual results vary.
What are the biggest complaints about IVIM Health?
Three patterns dominate: billing confusion around multi-month prepaid plans, app issues (especially on Android), and shipping delays on compounded refills. Clinical complaints — about the medication itself or the providers — are rare.
| BBB complaint category | Count (past 3 years) |
|---|---|
| Billing/Collection Issues | 32 |
| Product Issues | 28 |
| Delivery Issues | 11 |
| Order Issues | 9 |
| Customer Service Issues | 7 |
| Service/Repair Issues | 7 |
| Advertising/Sales Issues | 4 |
IVIM is BBB-accredited with an A+ rating and responds to complaints. Resolution patterns vary — some threads end in refunds or store credits after escalation. Before enrolling, read a handful of recent complaints yourself so you know what the specific friction points look like.
IVIM Health vs. the Best Alternatives
IVIM wins on all-in cost for compounded GLP-1s on longer commitments and on individualized weekly dose adjustment. If your priority is FDA-approved brand-name medication with insurance, Ro is the answer. If your priority is month-to-month compounded access with flat pricing, Eden is the cleanest alternative. If your priority is a mainstream consumer telehealth brand with monthly billing, Hims is the pick.
| Factor | IVIM Health | Ro (FDA-approved) | Eden (compounded, monthly) | Hims (mainstream monthly) |
|---|---|---|---|---|
| Best compounded sema, long-term rate | $143.75/mo effective (12-mo plan) | N/A (FDA-approved focus) | $249/mo ongoing, $149 first month | Varies |
| Best compounded tirz, long-term rate | $202.08/mo effective (12-mo plan) | N/A | $329/mo ongoing | Varies |
| FDA-approved brand options | Yes (insurance PA + Wegovy Pill self-pay) | Yes — Foundayo, Wegovy pill/pen, Zepbound pen/KwikPen, Mounjaro, Ozempic | Yes | Yes (via Novo Nordisk collab) |
| Insurance prior authorization | Yes (brand-name) | Yes — dedicated concierge | No (cash-pay) | Limited |
| Membership structure | $75/mo mandatory (1st mo free) | Ro Body — $39 first month, then $149/mo (or $74/mo annual prepay) | No membership fee | Monthly program billing |
| Multi-month commitment | Yes — committed through plan term | Monthly or annual plan | Month-to-month available | Monthly |
| Flat pricing at every dose | Yes | Yes | Yes (explicit flat-rate guarantee) | Varies by plan |
| Peer-reviewed clinical outcomes | Yes — 1,131-patient Obesity Pillars study | No published program study | No | No |
| Open FDA warning letter | Yes (Feb 20, 2026 — misbranding) | No | No | No |
| HSA/FSA accepted | Yes (verify membership fee eligibility) | Yes | Yes | Yes |
Who Should Actually Pick IVIM Health, and Who Should Skip It?
Pick IVIM Health if this sounds like you
- You want the lowest effective compounded monthly ($143.75/mo on 12-mo sema, $202.08/mo on 12-mo tirz)
- You can commit to at least a 6-month plan (12-month is the best rate)
- You value weekly individualized dose adjustments over fixed titration
- You want unlimited provider visits, coaching, and app-based tracking included
- You want a provider with peer-reviewed published outcomes
- You're comfortable with the February 2026 FDA warning letter in context
- You're not in Mississippi and your insurance doesn't cover brand-name GLP-1s
Skip IVIM Health if this sounds like you
- Your first choice is an FDA-approved brand-name GLP-1 → use Ro
- You need true month-to-month flexibility → use Eden or Hims
- Your coverage is Medicare, Medicaid, Tricare, or excludes weight-loss medications
- You consider the Feb 2026 FDA warning letter a dealbreaker
- You live in Mississippi
- You only want a prescription — no app, no coaching, no program
How to Sign Up for IVIM Health (Step by Step)
IVIM Health's enrollment starts with a free online health questionnaire and a free telehealth consultation. You only pay after you've met with a provider and chosen a plan. The first month of the $75 membership is free on select plans.
- Complete the free online questionnaire. Takes about 5–10 minutes. Covers medical history, weight goals, current medications, and basic eligibility.
- Schedule your telehealth consultation. Video or chat, depending on your state's telehealth rules. A licensed provider in your state reviews your history and determines clinical fit.
- Review your provider's treatment plan. The provider recommends a medication and explains starting dose and titration.
- Choose your plan length and pay. Shorter plans cost more per month; longer plans are cheaper per month but lock you in for the term.
- Medication is prescribed and shipped. 7–14 days for compounded. Use the IVIM app to track your shots, weight, and side effects from day one.
No card required to meet with a provider. Free first month of membership on select plans.
IVIM Health FAQs
Ready to Make the Call?
You came here to end the search, not start another one. Pick the path that matches what you just read.
Most readers who fit the profile above:
Start Your Free IVIM Health ConsultationNo payment required to meet with a provider. Free first month of membership on select plans.
If you want FDA-approved brand-name medication with insurance:
See Ro's FDA-Approved GLP-1 OptionsFoundayo, Wegovy pill, Wegovy pen, Zepbound pen, Zepbound KwikPen, Mounjaro, Ozempic. $39 first month, then as low as $74/month with annual plan paid upfront.
If you want compounded GLP-1 month-to-month with flat pricing:
See Eden's GLP-1 Program$149 first month, then $249/month ongoing. Same price at every dose. No membership fee.
Still not sure which GLP-1 program is right for you?
Take our free 60-second GLP-1 matching quizWe'll match you to the provider that best fits your insurance, budget, flexibility needs, medication preference, and state.
This page was researched and written by the Weight Loss Provider Guide Research Team. Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn affiliate commissions when readers enroll with providers mentioned on this page through our tracked links. Commission rates do not change our recommendations or what we verify. This page is not medical advice. GLP-1 medications are prescription medications and should only be started after evaluation by a licensed clinician.
Last verified: April 23, 2026. Next scheduled verification: May 23, 2026 (or immediately upon any material change).